Nicole Aristy
Pediatrics · Wilmington, NCNPI 1174722987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.
Across 60 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$175
- Novo Nordisk$65
- Johnson & Johnson$62
- Takeda Pharmaceuticals U.S.A., Inc.$61
- Corium, LLC$59
- Sanofi Pasteur Inc.$55
- plus $652 from 24 others
What the payments were for
- Food & beverage$1,11299%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $175 |
| Novo Nordisk | 4 | $65 |
| Johnson & Johnson | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Corium, LLC | 4 | $59 |
| Sanofi Pasteur Inc. | 2 | $55 |
| Ultragenyx Pharmaceutical Inc. | 2 | $49 |
| Ironshore Pharmaceuticals Inc. | 2 | $46 |
| Biogen | 2 | $46 |
| Merck | 3 | $45 |
| Springworks Therapeutics, Inc. | 2 | $43 |
| Tris Pharma Inc | 3 | $42 |
| Immedica Pharma US, Inc. | 2 | $37 |
| AstraZeneca | 2 | $33 |
| Organon | 1 | $32 |
| Neurelis, Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
| Boston Scientific | 2 | $28 |
| Harmony Biosciences LLC | 1 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Aucta Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Neos Therapeutics, LP | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $11 |
How this compares
$1,129 in reported general payments places this provider in the 85th percentile of 1,818 pediatrics providers in North Carolina.
Other pediatrics in Wilmington
- Dwight KoeberlDurham$8.4M
- Priya KishnaniDurham$5.8M
- James AndersonHigh Point$669K
- Joseph MuenzerChapel Hill$237K
- Ifeyinwa OsunkwoCharlotte$218K
- Edward SmithDurham$164K
- Katherine SmithRaleigh$133K
- James StillRaleigh$105K
- Richard BrugmanGastonia$73K
- Daniel LandiDurham$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.